Article
Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC).
International journal of cancer - 1 Oct 2015
Saadatmand Sepideh, Obdeijn Inge-Marie, Rutgers Emiel J, Oosterwijk Jan C, Tollenaar Rob A, Woldringh Gwendolyn H, Bergers Elisabeth, Verhoef Cornelis, Heijnsdijk Eveline A, Hooning Maartje J, de Koning Harry J, Tilanus-Linthorst Madeleine M
Abstract excerpt
Adding MRI to annual mammography screening improves early breast cancer detection in women with familial risk or BRCA1/2 mutation, but breast cancer specific metastasis free survival (MFS) remains unknown. We compared MFS of patients from the largest prospective MRI Screening Study (MRISC) with 1:1 matched controls. Controls, unscreened if<50 years, and screened with biennial mammography if ≥50 years, were...
Topics
- Adult
- Aged
- Breast Neoplasms
- Case-Control Studies
- Female
- Genes, BRCA1
- Genetic Predisposition to Disease
- Humans
- Magnetic Resonance Imaging
- Middle Aged
